Intelligence · Clinical Development
Pipeline search results
Programs matching “atezolizumab” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.
Quick answer
Showing 25 pipeline programs matching "atezolizumab" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.
Refine search
Search results
-
Atezolizumab
Hoffmann-La Roche
Breast Cancer
1 trial -
Atezolizumab
Hoffmann-La Roche
Melanoma
1 trial -
Atezolizumab
Jazz Pharmaceuticals Ireland Limited
Small-Cell Lung Cancer
1 trial -
Atezolizumab
Hoffmann-La Roche
Urothelial Carcinoma
2 trials -
Atezolizumab
Hoffmann-La Roche
Carcinoma, Hepatocellular
1 trial -
GO29431
Hoffmann-La Roche
Non-Squamous Non-Small Cell Lung Cancer, Squamous Non-Small Cell Lung Cancer
1 trial -
MO29872
Hoffmann-La Roche
Non-Small Cell Lung Cancer
1 trial -
WO29637
Hoffmann-La Roche
Renal Cell Carcinoma
1 trial -
YO29232
Hoffmann-La Roche
Carcinoma, Non-Small-Cell Lung
1 trial -
ATEZOLIZUMAB
The George Institute
Patients with metastatic tumours (colorectal, non-small cell lung, renal and sarcoma)
1 trial -
Association atezolizumab + BDB001 + RT
Eikon Therapeutics
Solid Tumor, Adult
1 trial -
Atezolizumab
Oncotelic Therapeutics
Metastatic Lung Non-Small Cell Carcinoma
1 trial -
Atezolizumab
Hoffmann-La Roche
Advanced Liver Cancers
1 trial -
Atezolizumab
The University of Hong Kong
NSCLC Stage IIIB
1 trial -
Atezolizumab
BEONE MEDICINES AUS PTY LTD
Advanced Liver Cancers
1 trial -
Atezolizumab
United Therapeutics Europe Ltd
Locally Advanced Hepatocellular Carcinoma
1 trial -
Atezolizumab
United Therapeutics Europe Ltd
Metastatic Colorectal Carcinoma
1 trial -
Atezolizumab
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Small-cell Lung Cancer
1 trial -
Atezolizumab
HALOZYME THERAPEUTICS, INC.
Pancreatic Ductal Adenocarcinoma
1 trial -
Atezolizumab
Arcus Biosciences
Prostate Adenocarcinoma
1 trial -
Atezolizumab
Syndax Pharmaceuticals
Metastatic Cancer
1 trial -
BEVACIZUMAB, ATEZOLIZUMAB
Pari Pharma GmbH
liver transplanted patients with advanced hepatocellular carcinoma
1 trial -
Atezolizumab
Jazz Pharmaceuticals Ireland Limited
Endometrial Cancer
1 trial -
Atezolizumab
Hoffmann-La Roche
Advanced Ovarian Cancer
1 trial
Frequently asked questions
What is the Clinical Development Intelligence Platform?
It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.
How does this compare to Evaluate Pharma or Citeline?
Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.
Where does pipeline data come from?
Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.
Can I follow a company or program for updates?
Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.